Waters Corporation $WAT Shares Purchased by Tema Etfs LLC

Tema Etfs LLC grew its holdings in shares of Waters Corporation (NYSE:WAT) by 44.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,380 shares of the medical instruments supplier’s stock after purchasing an additional 1,356 shares during the quarter. Tema Etfs LLC’s holdings in Waters were worth $1,313,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of WAT. IFP Advisors Inc increased its holdings in shares of Waters by 65.4% in the second quarter. IFP Advisors Inc now owns 134 shares of the medical instruments supplier’s stock valued at $51,000 after purchasing an additional 53 shares during the last quarter. CYBER HORNET ETFs LLC acquired a new position in Waters in the second quarter valued at about $53,000. MUFG Securities EMEA plc purchased a new position in shares of Waters during the 2nd quarter worth approximately $61,000. Creative Financial Designs Inc. ADV lifted its stake in Waters by 533.3% during the second quarter. Creative Financial Designs Inc. ADV now owns 190 shares of the medical instruments supplier’s stock worth $66,000 after purchasing an additional 160 shares in the last quarter. Finally, Steph & Co. purchased a new position in shares of Waters during the second quarter worth $73,000. 94.01% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of brokerages recently commented on WAT. Rothschild & Co Redburn started coverage on Waters in a report on Wednesday, October 8th. They set a “buy” rating and a $390.00 target price for the company. Wolfe Research upgraded shares of Waters from a “peer perform” rating to an “outperform” rating and set a $480.00 price target for the company in a research note on Wednesday, December 10th. Wells Fargo & Company raised their price target on Waters from $385.00 to $415.00 and gave the company an “equal weight” rating in a research note on Monday, December 15th. Weiss Ratings reiterated a “hold (c)” rating on shares of Waters in a report on Wednesday, October 8th. Finally, Cowen reissued a “hold” rating on shares of Waters in a report on Wednesday, November 5th. Two equities research analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and ten have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $395.00.

Waters Stock Performance

Shares of WAT stock opened at $393.87 on Tuesday. The stock has a fifty day moving average price of $387.62 and a 200 day moving average price of $339.24. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.08 and a current ratio of 1.53. The stock has a market cap of $23.46 billion, a PE ratio of 36.20, a P/E/G ratio of 3.32 and a beta of 1.16. Waters Corporation has a 1 year low of $275.05 and a 1 year high of $423.56.

Waters (NYSE:WAT) last issued its quarterly earnings data on Thursday, May 19th. The medical instruments supplier reported $2.29 EPS for the quarter. The firm had revenue of $608.55 million for the quarter. Waters had a net margin of 20.89% and a return on equity of 36.59%. Waters has set its FY 2025 guidance at 13.050-13.150 EPS and its Q4 2025 guidance at 4.450-4.550 EPS. Sell-side analysts forecast that Waters Corporation will post 12.86 earnings per share for the current fiscal year.

Waters Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.